Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ledderose

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 29, 1983
[Skin necroses and ergotism after preventive administration of heparin-dihydroergotamine]U Jehn, C Clemm, G Ledderose
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Combination chemotherapy with vinblastine, ifosfamide and cisplatin in bulky seminomaC Clemm, R Hartenstein, N Willich, et al.
Bone Marrow Transplantation|July 15, 2003
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CMLM Schleuning, W Günther, J Tischer, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 2001
[Allogeneic transplantation in malignant lymphoma]O J Stötzer, M Schleuning, G Ledderose, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 29, 2014
Specific stressors in endonasal skull base surgery with and without navigationK Stelter, M N Theodoraki, S Becker, et al.
Deutsche Medizinische Wochenschrift (1946)|October 25, 2002
[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results]C Schmid, M Weisser, G Ledderose, et al.
Neurology|March 12, 2003
Prospective evaluation of neurological complications after allogeneic bone marrow transplantationP Sostak, C S Padovan, T A Yousry, et al.
Leukemia & Lymphoma|April 8, 1999
The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantationC Salat, E Holler, H J Kolb, et al.
Bone Marrow Transplantation|October 19, 2004
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the diseaseM Weisser, M Schleuning, G Ledderose, et al.
Blood|December 15, 1990
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsH J Kolb, J Mittermüller, C Clemm, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|July 29, 1983
[Skin necroses and ergotism after preventive administration of heparin-dihydroergotamine]U Jehn, C Clemm, G Ledderose
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Combination chemotherapy with vinblastine, ifosfamide and cisplatin in bulky seminomaC Clemm, R Hartenstein, N Willich, et al.
Bone Marrow Transplantation|July 15, 2003
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CMLM Schleuning, W Günther, J Tischer, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 2001
[Allogeneic transplantation in malignant lymphoma]O J Stötzer, M Schleuning, G Ledderose, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 29, 2014
Specific stressors in endonasal skull base surgery with and without navigationK Stelter, M N Theodoraki, S Becker, et al.
Deutsche Medizinische Wochenschrift (1946)|October 25, 2002
[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results]C Schmid, M Weisser, G Ledderose, et al.
Neurology|March 12, 2003
Prospective evaluation of neurological complications after allogeneic bone marrow transplantationP Sostak, C S Padovan, T A Yousry, et al.
Leukemia & Lymphoma|April 8, 1999
The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantationC Salat, E Holler, H J Kolb, et al.
Bone Marrow Transplantation|October 19, 2004
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the diseaseM Weisser, M Schleuning, G Ledderose, et al.
Blood|December 15, 1990
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsH J Kolb, J Mittermüller, C Clemm, et al.
Pageof 3